Boston company to buy Alpine Immune Sciences for $4.9B

The Seattle biotech is developing a drug to treat kidney disease.

Source: bizjournals.com Health Care:Biotechnology headlines - April 11, 2024 Category: Biotechnology Authors: Don Seiffert Source Type: news